𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (E.H.D.P.) IN PAGET'S DISEASE

✍ Scribed by Fromm, Gunther; Schajowicz, Fritz; Mautalen, CarlosA.


Book ID
123209858
Publisher
The Lancet
Year
1975
Tongue
English
Weight
160 KB
Volume
306
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The effects of disodium ethane-hydroxy-
✍ John McClure πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 449 KB

## Abstract Systemic treatment with disodium ethane‐hydroxy‐1, 1‐diphosphonate is ineffective in inhibiting the calcergenic reactions induced in mouse skin by the lanthanides. In contrast, disodium dichloromethylene diphosphonate prevents lanthanide calcergy induced by 12 of the 15 compounds tested

Synthesis of osseous specific 32P-labele
✍ Lionel D. McCreary; Andrew J. Tofe; Marion D. Francis πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 French βš– 337 KB

High specific activity 32P-labeled disodium ethane-lhydroxy-1,l-diphosphonate has been prepared for specific use as a radiothera eutic ameliorative treatment of osseous tumors by reacting s2P-labeled phosphorus trichloride, acetic acid and water. This compound has been purified by crystallization of

A comparison of the inhibitory effects o
✍ J. McClure πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 637 KB

Both disodium pyrophosphate and disodium ethane-hydroxy-1, 1-diphosphate inhibit the reaction of simple calcergy induced in the mouse by lead acetate. The pyrophosphate is effective only by a direct interaction with the lead salt and the disphosphonate is effective only before the occurrence of hist